4 min read
The ₹1 Crore Pharma Fund Strategy: SBI vs Mirae vs Nippon
A data-driven deep dive into India’s top pharma mutual funds—SBI Healthcare, Mirae Asset Healthcare, Nippon Pharma, and ICICI Pharma. Discover real returns, rolling consistency, risk metrics, and the probability of earning 15%+ CAGR. Learn which fund actually builds long-term wealth and how to allocate like a pro
5 min read
Your Broker Wants You to Trade More
Why do most traders lose while brokers keep winning? Discover the hidden business model of stock brokers in India, the F&O trap, and the real reason over 90% of traders fail—before your next trade costs you more than you think
4 min read
India’s New Income Tax Rules (From April 1, 2026)
India’s new Income Tax rules from April 1, 2026 explained in detail: ₹12 lakh tax-free truth, Form 130 replacing Form 16, meal card benefits, PAN tracking, ITR changes, and why the system was completely rewritten
4 min read
₹70,000 Crore Gone in Hours: Inside the HDFC Bank Shock — and What Smart Money Is Doing Now
HDFC Bank’s ₹70,000 crore market cap erosion after its chairman’s exit signals a credibility shock—not a financial crisis. Here’s a deep-dive into valuation reset, governance risks, and what investors should do now
3 min read
🧪 Sai Parenterals IPO: ₹408 Cr Pharma Bet Trading at 70–110x — Growth Story or Overvaluation?
Sai Parenterals IPO analysis with RHP data: financials, valuation (70–110x P/E), risks, and growth outlook. Should you invest or avoid? Full forensic breakdown
4 min read
⚡ Powerica IPO: Balance Sheet Fix or Strategic Energy Play?
Powerica IPO analysis 2026: Deep dive into financials, RHP insights, valuation, risks, peer comparison, and listing outlook. Should you apply or avoid? Read this expert breakdown before investing
4 min read
The ₹5,000 Trap That Can Quietly Turn Into ₹50,000
Instant loan apps promise quick cash—but can trap you in a dangerous debt cycle. Discover how ₹5,000 can turn into ₹50,000 with hidden charges, high interest, and risky practices. Learn the red flags, real costs, and smarter alternatives before you borrow
3 min read
March 31 is Closer Than You Think…99% Indians Miss This Before March End
A complete financial year-end 2026 checklist covering tax savings, capital gains strategies, AIS reconciliation, and advanced financial planning. Optimize before March 31
3 min read
Cheap Tyre vs Crash Risk? — What Most Riders Get Wrong
Confused about which bike tyre to buy? Discover the best tyre brands in India with prices, features, and expert picks for city, highway, and performance riding
3 min read
This ₹0.12% Fund Beat Most Mutual Funds… But There’s a Catch
This low-cost ₹0.12% fund quietly delivered 28% returns — beating many mutual funds. But is ICICI Prudential Bharat 22 FOF a hidden gem or a risky PSU bet? Read before investing
Popular
2 years ago • 17 min read • 44431 views
2 years ago • 10 min read • 38183 views
1 year ago • 9 min read • 36123 views
1 year ago • 6 min read • 32886 views
Latest
2 days ago • 12 min read
3 days ago • 10 min read
4 days ago • 11 min read
1 week ago • 13 min read
Authors
Start Investing with ₹0 Brokerage
Open your free account and access all market training modules.
Open Account Online →Frequently Asked Questions
What topics are covered in Brokerage Free articles?
The blog covers stock markets, investing, mutual funds, insurance, taxation, and financial awareness.
Are the articles beginner-friendly?
Yes. The content is written in a simple way so beginners can understand it more easily.
Does the blog include stock market education?
Yes. Readers can find articles about market basics, trading ideas, and investment learning.
Can I read about mutual funds and insurance here?
Yes. The blog includes articles related to mutual funds, insurance, and long-term financial planning.
Are new articles added regularly?
Yes. New articles are added based on financial topics, market trends, and reader interest.